NCT06167356 Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
| NCT ID | NCT06167356 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Non Muscle Invasive Bladder Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2013-11-27 |
| Primary Completion | 2063-11-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000 participants in total. It began in 2013-11-27 with a primary completion date of 2063-11-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A database has been created and will be used in which data will be collected in electronic format relating to adult patients who underwent one of the following endoscopic resection surgeries: TURBK, MAPPING, TURBK SECOND LOOK, BLADDER BIOPSIES.
Eligibility Criteria
Inclusion Criteria: * 18 years or older * Patients with non-muscle invasive bladder cancer * Indication to cancer removal through endoscopic resection surgery * Ability to read and sign the informed consent Exclusion Criteria: * Age \<18 years * Inability to read and sign the informed consent
Contact & Investigator
Francesco Montorsi, MD
PRINCIPAL INVESTIGATOR
IRCCS Ospedale San Raffaele
Frequently Asked Questions
Who can join the NCT06167356 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Non Muscle Invasive Bladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06167356 currently recruiting?
Yes, NCT06167356 is actively recruiting participants. Contact the research team at montorsi.francesco@hsr.it for enrollment information.
Where is the NCT06167356 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06167356 clinical trial?
NCT06167356 is sponsored by IRCCS San Raffaele. The principal investigator is Francesco Montorsi, MD at IRCCS Ospedale San Raffaele. The trial plans to enroll 20,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.